title: Switching drugs midstream for patients with chronic myeloid leukemia.
authors.affiliation: Harvard Medical School, Boston, Massachusetts.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: DeAngelo
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D057915:Drug Substitution; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000401:mortality; D011379:Prognosis; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage; D012074:Remission Induction; D016896:Treatment Outcome
chemical_list: D047428:Protein Kinase Inhibitors